Viking Therapeutics, Inc.VKTXEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for endocrine, metabolic and inflammatory disorders with high unmet medical need. Its pipeline includes lead product candidates targeting non-alcoholic steatohepatitis (NASH), dyslipidemia, and hypogonadism, serving global patient populations across major regional markets.